Literature DB >> 24727650

Rising hospitalization rates for inflammatory bowel disease in Poland.

Arkadiusz Jakubowski, Edyta Zagórowicz, Ewa Kraszewska, Witold Bartnik.   

Abstract

INTRODUCTION: The incidence and prevalence of inflammatory bowel disease (IBD) in Poland is unknown.
OBJECTIVES: We aimed to define the rates of hospitalization for IBD and time trends in the past 2 decades. PATIENTS AND METHODS: Data were obtained from the database of the National Institute of Public Health (1991-1996 and 2003-2007). Data on hospitalizations for Crohn's disease (CD) and ulcerative colitis (UC) were extracted. Age-, sex-, and disease‑specific rates of hospitalization per 100,000 population were calculated.
RESULTS: During the years 1991-1996 and 2003-2007, the rate of hospitalization for IBD increased each year, rising from 12.50 to 30.61 per 100,000 population. Rising time trends were observed in both sexes. The hospitalization rate increased from 3.53 to 9.35 per 100,000 population for CD and from 8.97 to 21.26 per 100,000 population for UC. A rising time trend was observed in hospitalizations for CD in men aged from 0 to 39 years. A rising time trend for CD in women was observed between the years 2003 and 2007. The hospitalization rate for UC was higher in men (9.18 to 23.29 per 100,000) than in women (8.77 to 19.37 per 100,000). Rising time trends for UC were observed in the years from 2003 to 2007 in all men and women except for those aged from 40 to 64 years.
CONCLUSIONS: Hospitalization rates for IBD in Poland increased from 1991 to 1996 and from 2003 to 2007, with rising time trends in both sexes. For CD, the rising time trend in men was limited to younger age groups. The hospitalization rate for UC was significantly higher in men than in women.

Entities:  

Mesh:

Year:  2014        PMID: 24727650     DOI: 10.20452/pamw.2188

Source DB:  PubMed          Journal:  Pol Arch Med Wewn


  8 in total

1.  Increase in Hospital Discharges for Inflammatory Bowel Diseases in Chile Between 2001 and 2012.

Authors:  Felipe Bellolio Roth; Javier Gómez; Jaime Cerda
Journal:  Dig Dis Sci       Date:  2017-06-30       Impact factor: 3.199

Review 2.  Impact of thiopurines and anti-tumour necrosis factor therapy on hospitalisation and long-term surgical outcomes in ulcerative colitis.

Authors:  Christopher Alexakis; Richard Cg Pollok
Journal:  World J Gastrointest Surg       Date:  2015-12-27

Review 3.  Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications.

Authors:  Dorota Cibor; Renata Domagala-Rodacka; Tomasz Rodacki; Artur Jurczyszyn; Tomasz Mach; Danuta Owczarek
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 4.  Diet and nutritional factors in inflammatory bowel diseases.

Authors:  Danuta Owczarek; Tomasz Rodacki; Renata Domagała-Rodacka; Dorota Cibor; Tomasz Mach
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

5.  Zeolite-Containing Mixture Supplementation Ameliorated Dextran Sodium Sulfate-Induced Colitis in Mice by Suppressing the Inflammatory Bowel Disease Pathway and Improving Apoptosis in Colon Mucosa.

Authors:  Weida Lyu; Huijuan Jia; Chuanzong Deng; Kenji Saito; Seigo Yamada; Hisanori Kato
Journal:  Nutrients       Date:  2017-05-06       Impact factor: 5.717

6.  The prevalence, characteristics, and determinants of anaemia in newly diagnosed patients with inflammatory bowel disease.

Authors:  Małgorzata Woźniak; Magdalena Barańska; Ewa Małecka-Panas; Renata Talar-Wojnarowska
Journal:  Prz Gastroenterol       Date:  2019-03-12

7.  Characteristics of patients with moderate-to-severe ulcerative colitis treated with vedolizumab: results from a Polish multicenter, prospective, observational real-life study (the POLONEZ study).

Authors:  Halina Cichoż-Lach; Agata Michalak; Maria Kopertowska-Majchrzak; Piotr Eder; Kamila Stawczyk-Eder; Katarzyna Waszak; Renata Talar-Wojnarowska; Hubert Zatorski; Anna Solarska-Półchłopek; Jarosław Chmielnicki; Rafał Filip; Anna Pękala; Maria Janiak; Krzysztof Skrobot; Ewa Kasińska; Michał Krogulecki; Piotr Królikowski; Maria Kłopocka; Ariel Liebert; Elżbieta Poniewierka; Izabela Smoła; Anita Gąsiorowska; Aleksandra Kaczka; Joanna Wypych; Krzysztof Wojciechowski; Szymon Drygała; Edyta Zagórowicz
Journal:  Therap Adv Gastroenterol       Date:  2021-08-30       Impact factor: 4.409

8.  Differences in the intestinal microbiome of healthy children and patients with newly diagnosed Crohn's disease.

Authors:  Kinga Kowalska-Duplaga; Tomasz Gosiewski; Przemysław Kapusta; Agnieszka Sroka-Oleksiak; Andrzej Wędrychowicz; Stanisław Pieczarkowski; Agnieszka H Ludwig-Słomczyńska; Paweł P Wołkow; Krzysztof Fyderek
Journal:  Sci Rep       Date:  2019-12-11       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.